Prescribing information and facts for lecanemab includes a boxed warning about potential dangers connected to ARIA. Correct use recommendations focus on means to minimize ARIA threat, as does AAN direction. Pertaining to pharmacological interventions, three rules advise no pharmacologic intervention. The use of cholinesterase inhibitors for MCI is contraindicated in https://hermannf320nyi2.actoblog.com/profile